Avandia Alternatives Available

With the US Food and Drug Administration (FDA) severely restricting access to the diabetes medication, <"http://www.yourlawyer.com/topics/overview/avandia">Avandia, and the European Medicines Agency suggesting the controversial medication be banned, many diabetics are left wondering about safe alternatives. As we have written previously, this summer’s FDA hearings concluded that Avandia’s risks outweigh benefits; however, notes CNN, the panel was split over a ban.

In the US, about 24 million people—a figure that translates to about eight percent—have been diagnosed with diabetes, said CNN, noting that those with Type 2 diabetes total most—90 percent—of this figure, citing the National Diabetes Information Clearinghouse.

About 600,000 diabetics in the US take GlaxoSmithKline’s Avandia, but that number is expected to decline significantly thanks to the FDA’s action. Patients in the US will only have access to Avandia if they and their doctors attest that they have tried every other diabetes medicine and that patients have been made aware of Avandia’s cardiac side effects. Patients already taking Avandia who want to continue will have to sign statements that they understand the risks. But, says, CNN, there are other options.

Metformin, an oral medication “is generally accepted as the initial medical therapy choice for patients with type 2 diabetes,” said Dr. David Kendall, Chief Scientific and Medical Officer for the American Diabetes Association, wrote CNN. “It lowers the blood sugar without the risk of it going too low,” he added, quoted CNN. Metformin with sulfonylureas, which better enables the pancreas to produce additional insulin, are another option, according to Dr. David Nathan, director of the diabetes center at Massachusetts General Hospital, wrote CNN. “If your blood control isn’t working with metformin alone, this combination is often the next line of defense,” quoted CNN. Also, Metformin with insulin is an option, said Dr. Nathan, wrote CNN. “It’s also worth noting that insulin is the only medicine we treat people with that’s naturally occurring in the body,” said Nathan, quoted CNN.

Pioglitazone, in the same class of Avandia, known as Actos—the only drug in this class which will not been banned if Avandia is pulled, is another option, wrote CNN. “With all drugs in this class, there is a risk of fluid retention and weight gain, however, Actos has not been implicated to increase the risk of heart attack,” said Dr. Kendall, quoted CNN. Of note, Actos is not recommend for cardiac patients. DPP-4 inhibitors, a new class of drug that lowers blood glucose by helping produce insulin when needed, and which prevents “the liver from depositing stored glucose into the blood” is available as a pill, soon, as a weekly injection, said CNN.

Each medication has pros and cons; a comparison is accessible at the Agency for Healthcare Research and Quality at: http://www.effectivehealthcare.ahrq.gov/repFiles/OralHypo_Clin_07.02.08.pdf

As Dr. Kendal points out, “Anyone who has just developed diabetes, who can control their blood sugar with food intake, can manage with eating healthy and exercising and not taking a medication,” quoted CNN. “The absolute best alternative therapy to treat diabetes is to lose weight,” said Dr. Nathan. “The problem is that many patients fail, and that’s why we turn to medication,” he added, quoted CNN.

Centers for Disease Control (CDC) indicates that over 72 million U.S adults are obese, putting them at increased risk for a number of diseases, such as type 2 diabetes, said CNN. The National Diabetes Education Program offers information on seven areas in which to focus on the management of diabetes and blood sugar: It can be accessed here.

This entry was posted in Avandia, Pharmaceuticals. Bookmark the permalink.

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.